These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20138889)

  • 1. A single-domain llama antibody potently inhibits the enzymatic activity of botulinum neurotoxin by binding to the non-catalytic alpha-exosite binding region.
    Dong J; Thompson AA; Fan Y; Lou J; Conrad F; Ho M; Pires-Alves M; Wilson BA; Stevens RC; Marks JD
    J Mol Biol; 2010 Apr; 397(4):1106-18. PubMed ID: 20138889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function.
    Tremblay JM; Vazquez-Cintron E; Lam KH; Mukherjee J; Bedenice D; Ondeck CA; Conroy MT; Bodt SML; Winner BM; Webb RP; Ichtchenko K; Jin R; McNutt PM; Shoemaker CB
    Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32987745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity.
    Fan Y; Geren IN; Dong J; Lou J; Wen W; Conrad F; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD
    PLoS One; 2015; 10(8):e0135306. PubMed ID: 26275214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B.
    Fan Y; Dong J; Lou J; Wen W; Conrad F; Geren IN; Garcia-Rodriguez C; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD
    Toxins (Basel); 2015 Aug; 7(9):3405-23. PubMed ID: 26343720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH).
    Bakherad H; Mousavi Gargari SL; Rasooli I; Rajabibazl M; Mohammadi M; Ebrahimizadeh W; Safaee Ardakani L; Zare H
    Mol Biotechnol; 2013 Oct; 55(2):159-67. PubMed ID: 23666874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases.
    Tremblay JM; Kuo CL; Abeijon C; Sepulveda J; Oyler G; Hu X; Jin MM; Shoemaker CB
    Toxicon; 2010 Nov; 56(6):990-8. PubMed ID: 20637220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the structure and function of the protease domain of botulinum neurotoxins using single-domain antibodies.
    Lam KH; Tremblay JM; Perry K; Ichtchenko K; Shoemaker CB; Jin R
    PLoS Pathog; 2022 Jan; 18(1):e1010169. PubMed ID: 34990480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes.
    Fan Y; Garcia-Rodriguez C; Lou J; Wen W; Conrad F; Zhai W; Smith TJ; Smith LA; Marks JD
    PLoS One; 2017; 12(3):e0174187. PubMed ID: 28323873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum neurotoxins and botulism: a novel therapeutic approach.
    Thanongsaksrikul J; Chaicumpa W
    Toxins (Basel); 2011 May; 3(5):469-88. PubMed ID: 22069720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Algal chloroplast produced camelid VH H antitoxins are capable of neutralizing botulinum neurotoxin.
    Barrera DJ; Rosenberg JN; Chiu JG; Chang YN; Debatis M; Ngoi SM; Chang JT; Shoemaker CB; Oyler GA; Mayfield SP
    Plant Biotechnol J; 2015 Jan; 13(1):117-24. PubMed ID: 25229405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Llama-derived single-domain antibodies for the detection of botulinum A neurotoxin.
    Swain MD; Anderson GP; Zabetakis D; Bernstein RD; Liu JL; Sherwood LJ; Hayhurst A; Goldman ER
    Anal Bioanal Chem; 2010 Sep; 398(1):339-48. PubMed ID: 20582697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Domain Antibody Multimers for Detection of Botulinum Neurotoxin Serotypes C, D, and Their Mosaics in Endopep-MS.
    Harmsen MM; Cornelissen JC; van der Wal FJ; Bergervoet JHW; Koene M
    Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37755999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells.
    Lam KH; Perry K; Shoemaker CB; Jin R
    Toxins (Basel); 2020 Sep; 12(10):. PubMed ID: 32992561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and biochemical characterization of the protease domain of the mosaic botulinum neurotoxin type HA.
    Lam KH; Sikorra S; Weisemann J; Maatsch H; Perry K; Rummel A; Binz T; Jin R
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29688327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Insights into Rational Design of Single-Domain Antibody-Based Antitoxins against Botulinum Neurotoxins.
    Lam KH; Tremblay JM; Vazquez-Cintron E; Perry K; Ondeck C; Webb RP; McNutt PM; Shoemaker CB; Jin R
    Cell Rep; 2020 Feb; 30(8):2526-2539.e6. PubMed ID: 32101733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain.
    Adekar SP; Takahashi T; Jones RM; Al-Saleem FH; Ancharski DM; Root MJ; Kapadnis BP; Simpson LL; Dessain SK
    PLoS One; 2008 Aug; 3(8):e3023. PubMed ID: 18714390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of inhibition of botulinum neurotoxin type A light chain by two quinolinol compounds.
    Minnow YV; Goldberg R; Tummalapalli SR; Rotella DP; Goodey NM
    Arch Biochem Biophys; 2017 Mar; 618():15-22. PubMed ID: 28137423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum neurotoxin serotype F: identification of substrate recognition requirements and development of inhibitors with low nanomolar affinity.
    Schmidt JJ; Stafford RG
    Biochemistry; 2005 Mar; 44(10):4067-73. PubMed ID: 15751983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A yeast assay probes the interaction between botulinum neurotoxin serotype B and its SNARE substrate.
    Fang H; Luo W; Henkel J; Barbieri J; Green N
    Proc Natl Acad Sci U S A; 2006 May; 103(18):6958-63. PubMed ID: 16636286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A camelid single-domain antibody neutralizes botulinum neurotoxin A by blocking host receptor binding.
    Yao G; Lam KH; Weisemann J; Peng L; Krez N; Perry K; Shoemaker CB; Dong M; Rummel A; Jin R
    Sci Rep; 2017 Aug; 7(1):7438. PubMed ID: 28785006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.